FindTrial
Sign In

TO STUDY THE EFFECT OF ANTI-RHEUMATIC DRUGS ON ANTI CARBOMYLATED PROTEIN ANTIBODY AND QUALITY OF LIFE IN PATIENTS WITH RHEUMATOID ARTHRITIS

TO STUDY THE EFFECT OF ANTI-RHEUMATIC DRUGS ON ANTI CARBOMYLATED PROTEIN ANTIBODY AND QUALITY OF LIFE IN PATIENTS WITH RHEUMATOID ARTHRITIS

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2015/06/005878
Enrollment
60
Registered
2015-06-04
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- RHEUMATOID ARTHRITIS

Interventions

Control Intervention1: AGE AND SEX MATCHED HEALTHY INDIVIDUALS: AGE AND SEX MATCHED HEALTHY INDIVIDUALS Control Intervention2: PATIENT TAKING DMARDS FOR RHEUMATOID ARTHRITIS: PATIENT TAKING DMARDS FOR

Sponsors

DEPARTMENT OF PHARMACOLOGYLADY HARDINGE MEDICAL COLLEGE
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: ALL PATIENTS > 16 YRS, DIAGNOSED WITH ACR 1987 CRITERIA

Exclusion criteria

Exclusion criteria: 1.PATIENTS WITH RA ASSOCIATED THE OTHER CONNECTIVE TISSUE DISEASE(SLE,SCLERODERMA,ETC) 2.PREGNANT WOMEN 3.LACTATING MOTHERS 4.NON CONSENTING PATIENTS

Design outcomes

Primary

MeasureTime frame
Titre of anti-CarP anti bodies in the serum of patients of rheumatoid arthritis taking anti rheumatic drugs.Timepoint: At the time of enrolment and after 3 months of therapy—

Secondary

MeasureTime frame
DAS28 score and quality of life by SF36 questionnaireTimepoint: At the time of enrolment and 3 months after therapy—

Countries

India

Contacts

Public Contactsudhir kumar

LADY HARDINGE MEDICAL COLLEGE

lkg71@rediffmail.com919868234013

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026